BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  ImmunoGen, Inc. Reports First Quarter Fiscal Year 2012 Financial Results and Provides Quarterly Update

  October 28, 2011

   · 

  1 min read
• Biotech Bay

  Align Technology, Inc. Announces $150 Million Stock Repurchase Program

  October 28, 2011

   · 

  1 min read
• AusBiotech Ltd. Release: Bottom-line Boost for Australian Biotechs

  October 28, 2011

   · 

  3 min read
• Business

  Pacific Biosciences Announces Third Quarter Financial Results

  October 28, 2011

   · 

  1 min read
• Business

  HeartWare Announces Planned Departure of Chief Financial Officer

  October 28, 2011

   · 

  4 min read
• BioCapital

  Novavax, Inc. CEO Addresses U.S. Patent and Trademark Office (USPTO) on Behalf of the Biotechnology Industry Organization (BIO)

  October 28, 2011

   · 

  1 min read
• Drug Development

  Hybrigenics’ Specific Inhibitor of Ubiquitin-Specific Protease 7 (USP7) is Cytotoxic for Chronic Lymphocytic Leukaemia (CLL) Cells in Vitro

  October 28, 2011

   · 

  3 min read
• Business

  HeartWare Reports Third Quarter 2011 Revenues of $21.3 Million; 54% Increase From $13.8 Million in Third Quarter 2010

  October 28, 2011

   · 

  4 min read
• Business

  Lexicon Pharmaceuticals, Inc. to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results

  October 28, 2011

   · 

  2 min read
• Viroblock SA Closes Series C Financing Round

  October 28, 2011

   · 

  1 min read